Your browser doesn't support javascript.
loading
Plasmonics-enhanced spikey nanorattle-based biosensor for direct SERS detection of mRNA cancer biomarkers.
Li, Joy Q; Atta, Supriya; Zhao, Yuanhao; Hoang, Khang; Canning, Aidan; Strobbia, Pietro; Canick, Julia E; Cho, Jung-Hae; Rocke, Daniel J; Lee, Walter T; Vo-Dinh, Tuan.
Afiliação
  • Li JQ; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
  • Atta S; Department of Biomedical Engineering, Duke University, Durham, NC, 27705, USA.
  • Zhao Y; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
  • Hoang K; Department of Biomedical Engineering, Duke University, Durham, NC, 27705, USA.
  • Canning A; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
  • Strobbia P; Department of Biomedical Engineering, Duke University, Durham, NC, 27705, USA.
  • Canick JE; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
  • Cho JH; Department of Biomedical Engineering, Duke University, Durham, NC, 27705, USA.
  • Rocke DJ; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
  • Lee WT; Department of Biomedical Engineering, Duke University, Durham, NC, 27705, USA.
  • Vo-Dinh T; Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27705, USA.
Anal Bioanal Chem ; 2024 Oct 07.
Article em En | MEDLINE | ID: mdl-39373917
ABSTRACT
We present a plasmonics-enhanced spikey nanorattle-based biosensor for direct surface-enhanced Raman scattering (SERS) detection of mRNA cancer biomarkers. Early detection of cancers such as head and neck squamous cell carcinoma (HNSCC) is critical for improving patient outcomes in regions with limited access to traditional diagnostic methods. Our method targets Keratin 14 (KRT14), a promising diagnostic mRNA biomarker for HNSCC, using a sandwich hybridization approach with magnetic beads and SERS spikey nanorattles (SpNR). We synthesized SpNR with a core-gap-shell structure to enhance SERS signals, achieving a limit of detection of 90 femtomolar. A pilot study using clinical samples demonstrated the efficacy of our biosensor in distinguishing between tissue with positive or negative diagnosis for HNSCC, highlighting its potential for rapid and sensitive cancer diagnostics in low-resource settings. This plasmonic assay offers a promising avenue for portable and high-specificity detection of nucleic acid biomarkers, with implications for early cancer detection and improved patient care, especially in middle and low-resource settings.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Anal Bioanal Chem / Anal. bioanal. chem / Analytical and bioanalytical chemistry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Anal Bioanal Chem / Anal. bioanal. chem / Analytical and bioanalytical chemistry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha